Skip to main content
. 2009 Jan 20;72(3):268–272. doi: 10.1212/01.wnl.0000339486.63862.db

graphic file with name znl0030961970001.jpg

Figure Assembly of study sample from the Vitamin Intervention in Stroke Prevention (VISP) cohort

Recruitment for the VISP cohort is described in detail elsewhere.9 Briefly, patients with a presumptive diagnosis of acute ischemic stroke were screened. Patients with total homocysteine levels (tHcy) that exceeded defined thresholds were randomized for treatment with high- or low-dose vitamin therapy. A random sample of eligible subjects with the highest 10% of tHcy were included in the study.